URI Alleviates Tyrosine Kinase Inhibitors-Induced Ferroptosis by Reprogramming Lipid Metabolism in p53 Wild-Type Liver Cancers

Researchers uncovered that lipid metabolism reprogramming mediated by unconventional prefoldin RPB5 interactor (URI) endowed HCC with resistance to tyrosine kinase inhibitor-induced ferroptosis.